STTK

6.73

1.61% -0.11

Dopo l'orario di chiusura: 6.73

Shattuck Labs Inc (STTK)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$6.84

Aprire:

$7.02

Volume 24 ore:

1.84M

Relative Volume:

1.53

Capitalizzazione di mercato:

$675.44M

Reddito:

$1,000.00K

Utile/perdita netta:

$-48.81M

Rapporto P/E:

-8.6985

EPS:

-0.7737

Flusso di cassa netto:

$-39.95M

1 W Prestazione:

+10.87%

1M Prestazione:

-2.60%

6M Prestazione:

+4.83%

1 anno Prestazione:

+183.97%

Intervallo 1D:

$6.54

$7.09

Intervallo di 1 settimana:

$5.85

$7.42

Portata 52W:

$1.70

$8.33

Shattuck Labs Inc Stock (STTK) Company Profile

Nome

Shattuck Labs Inc

Settore

Healthcare (1064)

Industria

Biotechnology (595)

Telefono

512-900-4690

Indirizzo

500 W. 5TH STREET, AUSTIN

Dipendente

Cinguettio

Prossima data di guadagno

2026-11-05

Ultimi documenti SEC

STTK's Discussions on Twitter

Compare STTK vs VRTX, MRNA, REGN, ARGX, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
STTK Shattuck Labs Inc	6.73	609.20M	1,000.00K	-48.81M	-39.95M	-0.7737
VRTX Vertex Pharmaceuticals Inc	504.73	133.37B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	190.01	79.40B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	735.20	81.13B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	919.21	60.03B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	206.64	43.93B	742.00K	-1.37B	-1.07B	-7.0731

Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-04-27	Iniziato	Cantor Fitzgerald	Overweight
2026-03-06	Ripresa	Needham	Buy
2026-01-28	Iniziato	Piper Sandler	Overweight
2025-12-01	Aggiornamento	H.C. Wainwright	Neutral → Buy
2025-09-08	Iniziato	Wedbush	Outperform
2025-03-17	Iniziato	Leerink Partners	Outperform
2024-10-02	Downgrade	Citigroup	Buy → Neutral
2024-10-02	Downgrade	Needham	Buy → Hold
2024-10-01	Downgrade	H.C. Wainwright	Buy → Neutral
2024-06-17	Downgrade	BTIG Research	Buy → Neutral
2022-08-31	Iniziato	BTIG Research	Buy
2022-06-01	Iniziato	Citigroup	Buy
2022-05-02	Iniziato	H.C. Wainwright	Buy
2021-04-14	Iniziato	Berenberg	Buy
2021-01-11	Iniziato	Evercore ISI	Outperform
2020-11-03	Iniziato	Citigroup	Buy
2020-11-03	Iniziato	Cowen	Outperform
2020-11-03	Iniziato	Needham	Buy

Mostra tutto

Shattuck Labs Inc Borsa (STTK) Ultime notizie

Oct 01, 2026

Wedbush Lifts Price Target on Shattuck Labs to $14 From $11, Keeps Outperform Rating - marketscreener.com

Oct 01, 2026

Shattuck Labs Announces Phase 2 Clinical Trial of SL-325 in Hidradenitis Suppurativa and Appointment of Shoba Ravichandran, M.D., as Senior Vice President, Clinical Development - Investing News Network

Oct 01, 2026

Shattuck Labs plans phase 2 trial for SL-325 in hidradenitis suppurativa - Investing.com Nigeria

Oct 01, 2026

Shattuck Labs Plans Phase 2 Trial of Chronic Inflammatory Skin Disease Drug - marketscreener.com

Oct 01, 2026

Shattuck plans a trial of its drug in about 150 people with moderate-to-severe skin disease - Stock Titan

Oct 01, 2026

Sep 28, 2026

Preferred dividends of Shattuck Labs, Inc. – DUS:82S - TradingView

Sep 28, 2026

Sep 20, 2026

Shattuck Labs, Inc.(NasdaqGS: STTK) added to S&P Biotechnology Select Industry Index - marketscreener.com

Sep 20, 2026

Shattuck Labs, Inc.(NasdaqGS: STTK) added to S&P Global BMI Index - marketscreener.com

Sep 20, 2026

Sep 17, 2026

Shattuck Labs Q2 2026 Earnings: Clinical-Stage Balance Sheet in Focus as EPS Meets EstimatesEarnings Whisper Number - dars.gov.et

Sep 17, 2026

Return on invested capital % of Shattuck Labs, Inc. – TRADEGATE:82S - TradingView

Sep 17, 2026

Sep 16, 2026

Taxes of Shattuck Labs, Inc. – TRADEGATE:82S - TradingView

Sep 16, 2026

Sep 08, 2026

Shattuck Labs at Wells Fargo conference: DR3 bet takes center stage - Investing.com Canada

Sep 08, 2026

Shattuck Labs at Wells Fargo conference: DR3 bet takes center stage By Investing.com - Investing.com South Africa

Sep 08, 2026

Sep 04, 2026

SHATTUCK LABS STOCK : BIG PRICE RECOVERY | STTK STOCK Darpa Autonomous Drone Swarms (RwCs7APen5) - Mshale

Sep 04, 2026

Sep 02, 2026

Shattuck Labs Announces Participation in Upcoming September Investor Conferences - Investing News Network

Sep 02, 2026

Shattuck Labs (STTK) Gains 2.81% to $7.06 as Momentum Builds Above Key SupportBlock Trade Flow - dars.gov.et

Sep 02, 2026

Sep 01, 2026

Shattuck Labs: A Receptor-Side Bet On The TL1A Boom - Seeking Alpha

Sep 01, 2026

Aug 28, 2026

STTK Q2 2026 Earnings: Fractional EPS Miss Triggers 6.67% Selloff in Clinical-Stage BiotechUpward Estimate Revision - vinanet.vn

Aug 28, 2026

Aug 24, 2026

Raymond James Initiates Coverage on Shattuck Labs With Strong Buy Rating, $18 Price Target - marketscreener.com

Aug 24, 2026

Raymond James initiates Shattuck Labs stock with strong buy rating By Investing.com - Investing.com India

Aug 24, 2026

Raymond James initiates Shattuck Labs stock with strong buy rating - Investing.com

Aug 24, 2026

Aug 23, 2026

Shattuck (STTK) EPS and Revenue: The EPS Result Is Above Expectation at the Close; Share Response: Shares Move 3.86% Up for the Current SessionEarnings Expansion Phase - vinanet.vn

Aug 23, 2026

Aug 22, 2026

Shattuck (STTK) Momentum: Records a 3.86% Increase to $7.53 in the Latest Reading; Level Watch: the $7.15 to $7.91 Range Remains in Focus in the Latest SessionSweep Order Flow - vinanet.vn

Aug 22, 2026

Aug 21, 2026

Shattuck Labs expects ~$59.4M proceeds from exercised warrants - scanx.trade

Aug 21, 2026

Aug 20, 2026